Deferred Tax Assets, Valuation Allowance of ImmunityBio, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ImmunityBio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • ImmunityBio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $855,845,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $855,845,000 +$78,760,000 +10% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q4 2024 $777,085,000 +$128,641,000 +20% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q4 2023 $648,444,000 +$156,689,000 +32% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $491,755,000 +$116,595,000 +31% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q4 2021 $375,160,000 +$113,716,000 +43% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $261,444,000 +$63,414,000 +32% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $198,030,000 +$53,257,000 +37% 31 Dec 2019 8-K/A 22 Apr 2021
Q4 2018 $144,773,000 +$25,753,000 +22% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q4 2017 $119,020,000 -$8,321,000 -6.5% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q4 2016 $127,341,000 +$58,197,000 +84% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q4 2015 $69,144,000 +$68,982,000 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $162,000* 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.